Meridian Bioscience (VIVO) Peer Comparison
$4.06
$-0.22
(-5.14%)
As on 28-Aug-2026 16:06EDT
Market cap
$134 Mln
Revenue (TTM)
$302 Mln
P/E Ratio
--
P/B Ratio
7.9
Div. Yield
0 %
Edit
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
134 | 11,869 | 10,461 | 7,433 | 7,065 |
Revenue ($ Mln) |
0 | 6,206 | 5,487 | 2,578 | 2,595 |
Net Profit ($ Mln) |
-46.70 | 621.00 | 378.70 | -142.03 | 274.99 |
Net Margin (%) |
-0.89 | 10.01 | 6.90 | -5.51 | 10.60 |
RoE (%) |
253.87 | 16.23 | 16.18 | -32.84 | 30.39 |
Price to Earnings |
-- | 20.19 | 28.18 | -- | 26.88 |
Price-To-Book |
7.90 | 4.59 | 4.29 | 22.38 | 8.42 |
Income Statement ($ Mln)
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.02 | 5,373.20 | 4,260.49 | 1,476.51 | 2,431.29 |
|
Cost of Revenue
|
-0.03 | 3,140.00 | 3,592.90 | 303.38 | 1,576.94 |
|
Gross Profit
|
0.04 | 2,233.20 | 667.59 | 1,173.14 | 854.35 |
|
Operating Expenses
|
8.62 | 1,368.70 | 309.28 | 1,111.23 | 487.86 |
|
Operating Profit (EBIT)
|
-8.61 | 864.50 | 358.30 | 61.90 | 366.49 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-44.22 | 749.60 | 386.09 | 71.71 | 399.47 |
|
Provision for Tax
|
-- | 150.20 | 87.64 | -54.33 | 97.47 |
|
Profit after Tax (Net Income)
|
-46.70 | 455.70 | 297.97 | 126.04 | 302.00 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 452.90 | -- | -- | 302.00 |
Liabilities ($ Mln)
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-40.54 | 2,067.00 | 1,837.11 | 476.72 | 1,118.99 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
23.85 | 2,844.50 | 2,085.50 | 9.46 | 263.89 |
|
Current Liabilities
|
54.13 | 841.00 | 743.43 | 221.37 | 285.70 |
|
Total Liabilities
|
37.43 | 6,534.70 | 4,669.36 | 707.54 | 1,668.58 |
Assets ($ Mln)
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
19.77 | 5,647.80 | 3,511.72 | 311.71 | 1,273.83 |
|
Current Assets
|
17.66 | 886.90 | 1,157.63 | 395.83 | 394.75 |
|
Total Assets
|
-- | 6,534.70 | 4,669.36 | 707.54 | 1,668.58 |
|
Total Debt*
|
-- | 2,713.80 | 1,974.47 | 11.35 | 140.84 |
|
Net Current Assets
|
-36.47 | 45.90 | 414.20 | 174.46 | 109.05 |
Cashflow ($ Mln)
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.49 | 1,002.80 | 347.19 | 251.08 | 417.50 |
|
Cash Flow from Investing Activities
|
-- | -653.30 | -390.05 | -19.05 | -143.91 |
|
Cash from Financing Activities
|
2.72 | -330.60 | -2.16 | -107.85 | -359.19 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
253.87 | 9.74 | 8.31 | 29.94 | 23.94 |
|
ROE (%)
|
253.87 | 24.54 | 17.90 | 30.71 | 27.12 |
|
ROA (%)
|
-94.49 | 7.21 | 6.74 | 21.94 | 18.10 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-291,875.00 | 8.48 | 6.99 | 8.54 | 12.42 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-1.00 | 0.12 | 0.14 | 0.69 | 0.07 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-91.75 | 29.46 | 42.30 | 635.28 | 10.82 |
|
EPS Growth (%)
|
-0.92 | 0.28 | 0.40 | 5.66 | 0.13 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 20.73 | 26.12 | 46.18 | 26.30 |
|
Price / Book Value
|
-- | 4.57 | 4.24 | 12.21 | 7.10 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 10.14 | 19.29 | 62.30 | 17.03 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.31 | 1.07 | 0.02 | 0.13 |
|
Short term debt to equity ratio
|
-- | 0.08 | 0.05 | 0.00 | 0.04 |
|
Current Ratio
|
0.33 | 1.05 | 1.56 | 1.79 | 1.38 |
|
Quick Ratio
|
0.30 | -- | -- | 1.50 | 1.35 |
|
Interest Coverage
|
-- | 6.46 | 47.60 | -- | 225.42 |
Operating Efficiency Ratios
| Meridian Bioscience (VIVO) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.00 | 11.14 | 13.38 | 0.41 | 7.04 |
|
Asset Turnover
|
0.00 | 0.85 | 0.96 | 2.57 | 1.46 |
|
Receivable days
|
18,821.79 | 41.14 | 45.22 | 1.59 | 26.49 |
|
Inventory Days
|
-25,438.99 | 8.46 | -- | 52.31 | 2.34 |
|
Payable days
|
-126,471.19 | 19.83 | 9.75 | 80.81 | 12.53 |
|
Cash Conversion Cycle
|
119,854.00 | 29.76 | -- | -26.92 | 16.30 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
